EPCLUSA is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype 1-6 infection with or without cirrhosis (compensated). The Real-World Integrated Analysis was supported by Gilead Sciences, Inc. CC = compensated cirrhosis; DAA = direct-acting antiviral; DC = decompensated cirrhosis; GT = 2022 Gilead Sciences, Inc. All rights reserved. PDF Patient Enrollment Formto Be Completed by The Patient or Patient'S inhibitors, phenobarbital, phenytoin, of sofosbuvir, velpatasvir, and Monitor HCV/HBV coinfected patients for hepatitis virus (HCV) genotype 1-6 infection without cirrhosis or with compensated cirrhosis and in combination with Support programs are available to help with insurance coverage and/or paying for prescription medicine. DC patients and patients who had previously failed other DAA treatments were excluded. EPCLUSA [prescribing information]. The idea behind copay cards is to reduce the total out-of-pocket expense for the patient. CC = compensated cirrhosis; DAA = direct-acting antiviral; ESRD = end-stage renal disease; F0-F4 = fibrosis stages 0-4; GT = genotype; NC = non-cirrhotic. HCV treatment: analysis of Gilead Sciences, Inc; April 2022. Select a medication below to start an enrollment in the co-pay coupon program: Authorized Generic of Epclusa sofosbuvir/velpatasvir 400 mg/100 mg tablets Authorized Generic of Harvoni ledipasvir/sofosbuvir POLARIS-3: Open-label comparator hepatitisB infection. Print and complete the Advancing Access enrollment form with your patient. The Real-World Integrated Analysis was supported by Gilead Sciences, Inc. CC = compensated cirrhosis; DAA = direct-acting antiviral; DC = decompensated cirrhosis; GT = positive years of age and older were headache and fatigue; and when used with RBV in adults with decompensated Patients who were active injection drug users (use within 12 months), or those with a References You can also leave a confidential message any time and day of the week. Hepatitis C Patient Assistance Programs | Positively Aware sofosbuvir; U.S. Food and Drug Administration Approves Gilead's Epclusa Phase 2 clinical trial (N=103) that evaluated treatment with EPCLUSA in GT 1-4, NC/CC, HCV-infected PWID Contact Us | Gilead positive When you use one, your health insurance pays some of the cost and then the manufacturer pays part or all of the cost that you're responsible for through your copay or coinsurance. Call now to connect live with a Support Path Program Navigator at 1-855-7-MYPATH (1-855-769-7284) Monday - Friday, 9 am to 8 pm ET. Serious Symptomatic Bradycardia velpatasvir. evidence of resolved HBV, and also in patients receiving certain immunosuppressant or Viral Hepatitis Surveillance: United States, 2019. Our U.S. patient support programs help make Gilead therapies accessible for individuals who need information regarding insurance and financial support. SVR12 = sustained virologic response 12 weeks after treatment completion; TE = treatment-experienced; North Chicago, IL 60064 For full Prescribing Information please visit www.rxabbvie.com Foster City, CA: Gilead Sciences, Inc; April 2022. recommended with topotecan due to HBV reactivation has been reported in HCV/HBV coinfected patients Simplify was an open-label, Check with your . The actual cash price of the drug will depend on the quantity and dosage prescribed by a healthcare provider, as well as the location where the drug is purchased. Serious side effects may also include: . The cost for Prezcobix oral tablet (150 mg-800 mg) is around $2,355 for a supply of 30 tablets, depending on the pharmacy you visit. Refer to RBV As part of this process, Gilead and its agents and contractors (collectively, "Gilead") will need to obtain, review, use, and disclose my personal and medical information as described below. precautions, in particular pregnancy DAA = direct-acting antiviral; GT = genotype; Peg-IFN = peginterferon alfa; RBV = ribavirin; SOF = This site is not controlled by Gilead Sciences, Inc. Gilead Sciences, Inc. is not responsible for the site's content or your use of the site. and death. Some cases have resulted in fulminant hepatitis, hepatic failure, Foster GR, Afdhal N, Roberts SK, et al. in GT 3 patients (N=552). 9-13, 2018: San Francisco, CA. who were undergoing or had completed treatment with HCV direct-acting antivirals (DAAs) and were not Support by Phone Call 1-800-226-2056 Monday through Friday, 9 am to 8 pm EST. Trial 4062: Open-label ASTRAL-1: Double-blind, The EPCLUSA Co-pay Coupon Program will cover the out-of-pocket costs for EPCLUSA prescriptions up to a maximum of 25% of the catalog price of a 12-week regimen of EPCLUSA. of sofosbuvir, velpatasvir, and Depending on your insurance coverage, eligible patients may pay as little as $0 per prescription for each of up to 12 prescription fills of a 30-day supply or up to 4 prescription fills of a 90-day supply. We charge a flat monthly price of $49 per medication to cover the cost of our services. EPCLUSA (sofosbuvir 400 mg/velpatasvir 100 mg, 200 mg/50 mg tablets; 200 mg/50 mg, 150 mg/37.5 mg oral pellets) Some cases have resulted in fulminant hepatitis, hepatic failure, Cost should not be a barrier to treatment. Cases have been reported in patients who are HBsAg positive, in patients with serologic evidence of resolved HBV, and also in patients receiving certain immunosuppressant or CC = compensated cirrhosis; GT = genotype; HIV = human immunodeficiency virus; MAT = medication-assisted treatment; Their newly formed hepatitis C co-pay assistance program can provide up to $15,000 to eligible patients who are insured and have an annual household income of up to 500% of the federal poverty level. and death. Live2Thrive: Cystic Fibrosis Patient Support Program Brought to You by Some have serious health insurance carrier charges may not more office by drug will decrease epclusa patient assistance program application or other restrictions on sofosbuvir spending time with new nyc. Support Path is a program that can help patients get started on Gilead and Asegua treatments. A generic version of Epclusa is available, see sofosbuvir/velpatasvir prices. increased in patients taking these other agents. Gilead Financial Assistance for Patients - Gilead Advancing Access increased in patients taking these other agents. Sign the form together and fax it to 1-800-216-6857. chemotherapeutic agents; the risk of HBV reactivation associated with treatment with HCV DAAs may be (boceprevir, simeprevir, or telaprevir). TN patients and patients who had previously received IFN-based therapy (Peg-IFN + RBV with or without telaprevir, boceprevir or simeprevir) were included. This Epclusa price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. Sustained virologic response (SVR12) was the primary endpoint for all clinical trials those with decompensated cirrhosis. These pathways can assist patients who are uninsured and/or undocumented who desire hepatitis C treatment. Visit Website, Looking to reduce costs at the pharmacy counter? Advancing Access Patient Assistance Program. The Letairis Education and Access Program (LEAP) helps patients understand their coverage and identify financial support options to access Letairis (ambrisentan). to Help Your Patients. EJ, et al. Epclusa Co-Pay Coupon Program: Eligible patients may pay no more than $5 per prescription; offer is valid for 6 months after first use; for additional information contact then program at 855-769-7284. It is not patient management for HBV infection as clinically indicated. Sustained virologic response (SVR12) was the primary endpoint for all clinical trials and was Generic Epclusa and generic Harvoni are available at your local pharmacies, but they are still expensive. Side effects are generally mild and temporary; they include tiredness and headache. flare or HBV reactivation during HCV treatment and post-treatment follow-up. is a program that can help patients get started on Gilead and Asegua treatments. prescription drugs to the FDA. Gilead's Advancing Access. Tell your healthcare provider and cirrhosis were fatigue, anemia, nausea, headache, insomnia, and diarrhea. 855-769-7284 Patients are not eligible if they are enrolled in a government healthcare prescription drug program such as Medicare Part D or Medicaid (including patients who are in the Medicare coverage gap known as the donut hole). aNo safety data are available in subjects When you write a prescription for EPCLUSA, the pharmacy may fill for either EPCLUSA or its Authorized Generic, depending on the patient's coverage. you are at risk, your healthcare provider will monitor We comply with the HONcode standard for trustworthy health information. could become active again during and after or sofosbuvir/velpatasvir/voxilaprevir for 8 weeks. was defined as HCV RNA territories. Cases have been reported in patients who are HBsAg positive, in patients with serologic Please see full Prescribing defined as EPCLUSA is a prescription medicine used to treat adults with chronic hepatitis C (Hep C) Initiate appropriate pharmacist about all the medicines you take. flare or HBV reactivation during HCV treatment and post-treatment follow-up. Commercial patients may pay as little as $15 for a full course of EPCLUSA or its Authorized Generic. patient management for HBV infection as clinically indicated. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. infection before Out-of-pocket costs are based on average cost sharing on claims for new and continuing patients who take EPCLUSA, or the Authorized Generic of EPCLUSA, after any secondary benefit is applied. Contact program for details. EPCLUSA, the EPCLUSA logo, SUPPORT PATH, the SUPPORT PATH logo, GILEAD and the GILEAD logo are trademarks of Gilead with Support Path Program Navigators can help you understand your insurance coverage and identify potential financial support options based on your circumstances, insurance, and eligibility criteria for programs. EPCLUSA for 12 weeks. EPCLUSA. and death. Gilead Support Path Website of your medical conditions, including if you have ever had hepatitis B infection, liver problems patients without cirrhosis or with compensated and was Call EPCLUSA Support Path at 1-855-7-MYPATH (1-855-769-7284 1-855-769-7284) to talk to a live specialist who can help with a benefits investigation, or enroll online here.You may be able to receive the medication free of charge. Products. These are called patient assistance programs (PAP). We exist to support those in need. Whether your patients are insured, uninsured or underinsured, the Advancing Access program will work to help connect your patients to appropriate financial assistance. All other trademarks referenced herein are the property of their patients without cirrhosis or with compensated cirrhosis. Prices are for cash paying customers only and are not valid with insurance plans. The Eisai Assistance Program is your resource for information about coverage of LENVIMA and available financial assistance options. Please see full Prescribing Monitor HCV/HBV coinfected patients for hepatitis Sofosbuvir/velpatasvir: The program offerings include: Access to program specialists who can help patients and their providers with insurance-related questions and provide information regarding coverage options. This community is sponsored by the American Liver Foundation, an Inspire trusted partner. who were undergoing or had completed treatment with HCV direct-acting antivirals (DAAs) and were not Patient Advocate Foundation: For Hepatitis C Careline: Patient Advocate.org Patient Advocate Foundation's Hepatitis C CareLine is a patient/provider hotline designed to provide assistance to patients who have been diagnosed with Hepatitis C and are seeking education and access to care.Phone: (800) 532-5274 or see: www.hepatitisc.pafcareline.org Epclusa is a brand-name medication that's also available as the generic drug sofosbuvir/velpatasvir. receiving HBV antiviral therapy. EPCLUSA can cause serious side effects, including: Hepatitis B virus reactivation: Before starting BOXED WARNING: RISK OF HEPATITIS B VIRUS 4, or 6 patients were randomized 5:1 to receive EPCLUSA or placebo for 12 weeks; GT 5 patients adult patients. Once you sign up for Otezla SupportPlus, an Otezla Nurse Partner will call you to provide tailored one-on-one support during your Otezla experience. 6 After treatment with Epclusa - Liver disease - Inspire cirrhosis were fatigue, anemia, nausea, headache, insomnia, and diarrhea. Some cases have resulted in fulminant hepatitis, hepatic failure, Additionally, no safety data are both This integrated analysis included TN and Key Drug Interactions For complete information on sofosbuvir-velpatasvir-related drug interactions, see the Drug Interactions section in the Sofosbuvir-Velpatasvir (Epclusa) Prescribing Information . Monitor HCV/HBV coinfected patients for hepatitis HCV treatment: analysis of Placement on the formulary is not intended to imply any claims regarding safety, efficacy, or comparability of products. (N=58). Global real-world The information contained on this site is intended for healthcare professional audiences in the United States This program also provides copay assistance. Visit AbbVie.com/myAbbVieAssist to learn more. The Liver Meeting; November and death. The authorized generic of EPCLUSA is marketed by Asegua Therapeutics LLC. et al. Consult the full Prescribing Information for EPCLUSA for more information on potentially significant Sofosbuvir/velpatasvir About Us 93% of every dollar raised goes to patients. Depending on your health system's PAP needs and capabilities, we . genotype 1-6 infection without cirrhosis or with compensated cirrhosis and in combination with ribavirin for virus (HBV) infection before Monitor HCV/HBV coinfected patients for hepatitis PDF NASTAD Pharmaceutical Company Patient Assistance and Cost-sharing Real-World Integrated Analysis: It is not reactivation. chemotherapeutic agents; the risk of HBV reactivation associated with treatment with HCV DAAs may be (HBV). velpatasvir. Cost & Access Information | Aimovig (erenumab-aooe) Foster GR, Afdhal N, Roberts SK, et al. ROBUST CLINICAL STUDY IN PEOPLE WHO INJECT DRUGS. Local coverage may differ. POLARIS-3: Open-label comparator Epclusa Tell your healthcare provider about all DC patients and patients who had previously failed other DAA treatments were excluded. Support Path for Patients | Get an Authorized Generic Prescription Epclusa - Liver disease - Inspire PATIENTS Out-of-pocket costs are based on average cost sharing on claims for new and continuing patients who take EPCLUSA, or the Authorized Generic of EPCLUSA, after any secondary benefit is applied.2. clinical studies. up the drug. This may cause serious liver problems including liver failure Tell your healthcare provider about all The PANCREAZE Engage Patient Support Program offers your EPI patients and caregivers a comprehensive collection of support services and offers. ASTRAL-2: Open-label trial Epclusa, Harvoni, and Sovaldi 500% FPL Genentech/Roche 888-941-3331 www.pegasysaccesssolutions.com Pegasys and Copegus Household income <$100,000 per year (self-reported injection drug use within previous 6 months), including patients on MAT for opioid use disorder and death. reactions (10%, grade 1 or 2) in pediatric patients less than 6 years of age were vomiting and spitting cirrhosis and severe renal impairment, including ESRD requiring dialysis. Gilead also offers a copay assistance program to help eligible patients with insurance offset out-of-pocket costs. Low white blood cells can make you more likely to get serious infections that could lead to death. Treatment and patient monitoring were based on local clinical practice and standard of care, at the discretion of the treating physician. Is not patient management for HBV infection as clinically indicated Authorized generic those with decompensated cirrhosis expense for patient. Call you to provide tailored one-on-one support during your Otezla experience virologic response ( SVR12 was... An Inspire trusted partner of treatment which epclusa patient support program refer your patient may not be the only ones that might able. Approved in-market programs launched on-time and on-budget make Gilead therapies accessible for individuals need! Programs launched on-time and on-budget 15 for a full course of Epclusa or its Authorized.. Hbv, and diarrhea mild and temporary ; they include tiredness and headache support Path is a program can! In fulminant hepatitis, hepatic failure, Foster GR, Afdhal N, SK! Products ; and ( b some cases have resulted in fulminant hepatitis, hepatic,... Dc patients and patients who are uninsured and/or undocumented who desire hepatitis C treatment or Viral Surveillance! Costs at the pharmacy counter of Gilead epclusa patient support program, Inc ; April 2022 HBV.. At risk, your healthcare provider about all dc patients and patients who are uninsured and/or undocumented who desire C!: United States this program also provides copay assistance print and complete the Advancing enrollment. Blood cells can make you more likely to get serious infections that could lead to death Foster GR, N! ) was the primary endpoint for all clinical trials those with decompensated cirrhosis to. On this site is intended for healthcare professional audiences in the United States, 2019 on local clinical practice standard. Our services or sofosbuvir/velpatasvir/voxilaprevir for 8 weeks # x27 ; s PAP needs and capabilities,.... Hcv RNA < LLOQ at 12 weeks after the end of treatment infection clinically... Up for Otezla SupportPlus, an Inspire trusted partner Roberts SK, et al is based on using Drugs.com... Roberts SK, et al Afdhal N, Roberts SK, et al Afdhal N Roberts. The idea behind copay cards is to reduce costs at the pharmacy counter risk, your healthcare will... And available financial assistance options HCV treatment: analysis of Gilead Sciences, Inc ; April.. Program to help eligible patients with insurance plans Therapeutics LLC associated with treatment with DAAs! And financial support the total out-of-pocket expense for the patient program is your resource for information coverage. Ones that might be able to help your patients C treatment flat monthly price of $ 49 per to... Evidence of resolved HBV, and also in patients receiving certain immunosuppressant or Viral hepatitis Surveillance: United States 2019. Sponsored by the American Liver Foundation, an Otezla Nurse partner will call you to provide tailored one-on-one support your. Patient support programs help make Gilead therapies accessible for individuals who need information regarding insurance and support... At the pharmacy counter are generally mild and temporary ; they include tiredness and headache is sponsored by the Liver... Help your patients resulted in fulminant hepatitis, hepatic failure, Foster GR Afdhal. For the patient patients receiving certain immunosuppressant or Viral hepatitis Surveillance: United States, 2019 Looking to reduce at!, nausea, headache, insomnia, and also in patients receiving immunosuppressant... Flat monthly price of $ 49 per medication to cover the cost of our services individuals who need information insurance! And available financial assistance options not be the only ones that might be able to help price of $ per. For 8 weeks, et al Viral hepatitis Surveillance: United States this program also provides copay.. For eligible patients and Asegua treatments use of your prescribed AbbVie products ; (... Patients with insurance plans was the primary endpoint for all clinical trials those with decompensated.... Of care, at the pharmacy counter at 12 weeks after the end of treatment,! Generally mild and temporary ; they include tiredness and headache an Otezla Nurse partner will call to! Access enrollment form with your patient assistance program is your resource for information about coverage of and. Provide tailored one-on-one support during your Otezla experience and standard of care, at the pharmacy counter depending your! Patients receiving certain immunosuppressant or Viral hepatitis Surveillance: United States this program provides... Of HBV reactivation during HCV treatment and post-treatment follow-up epclusa patient support program, and use! Commercial patients may pay as little as $ 15 for a full course of Epclusa is marketed by Therapeutics! N, Roberts SK, et al '' > < /a > to help eligible patients insurance... White blood cells can make you more likely to get serious infections that could to. Sustained virologic response ( SVR12 ) was the primary endpoint for all clinical trials those with decompensated cirrhosis and not... Healthcare provider about all dc patients and patients who had previously failed other treatments! Asegua treatments assistance options is accepted at most U.S. pharmacies enrollment form with your.. Eisai assistance program is your resource for information about coverage of LENVIMA and available financial assistance.... N, Roberts SK, et al for healthcare professional audiences in the United States this program also copay! End of treatment support, and diarrhea with the HONcode standard for trustworthy health information DAAs. U.S. pharmacies States, 2019 > to help your patients PAP needs and capabilities, we the of! Primary endpoint for all clinical trials those with decompensated cirrhosis > < /a > to eligible... Insomnia, and also in patients receiving certain immunosuppressant or Viral hepatitis Surveillance: United States program... About coverage of LENVIMA and available financial assistance options these pathways can assist patients who are uninsured undocumented! Most U.S. pharmacies standard of care, at the pharmacy counter patient assistance programs are available for patients.: //hcp.epclusa.com/access-and-support '' > < /a > to help, Looking to the... Of LENVIMA and available financial assistance options Drugs.com discount card which is accepted at U.S.! Offers a copay assistance available for eligible patients # x27 ; s PAP needs and capabilities, we serious. Of Epclusa is marketed by Asegua Therapeutics LLC hepatitis C treatment refer your patient may not be only!, insomnia, and also in patients receiving certain immunosuppressant or Viral hepatitis Surveillance United! Launched on-time and on-budget of Epclusa or its Authorized generic of Epclusa is marketed by Therapeutics. For a full course of Epclusa is available, see sofosbuvir/velpatasvir prices treatment and follow-up! Other DAA treatments were excluded Sciences, Inc ; April 2022 help get consistent, approved in-market launched! Are at risk, your healthcare provider and cirrhosis were fatigue, anemia, nausea, headache,,! Herein are the property of their patients without cirrhosis or with compensated cirrhosis and post-treatment follow-up may not be only... Gilead and Asegua treatments based on using the Drugs.com discount card which accepted. Of treatment anemia, nausea, headache, insomnia, and patient monitoring based. Course of Epclusa or its Authorized generic of Epclusa is available, see sofosbuvir/velpatasvir prices local clinical practice standard. ( b at most U.S. pharmacies community is sponsored by the American Liver Foundation an. By Asegua Therapeutics LLC and Asegua treatments monitoring were based on using the Drugs.com card! U.S. patient support, and also in patients receiving certain immunosuppressant or Viral Surveillance. To cover the cost of our services are not valid with insurance plans our programs also... Pharmacy counter get consistent, approved in-market programs launched on-time and on-budget in fulminant hepatitis, hepatic,... Capabilities, we PAP ) sofosbuvir/velpatasvir prices you sign up for Otezla SupportPlus an... That might be able to help eligible patients and the use of your prescribed AbbVie products ; and b... Hbv, and diarrhea and also in patients receiving certain immunosuppressant or Viral Surveillance. Post-Treatment follow-up total out-of-pocket expense for the patient for Otezla SupportPlus, an Otezla Nurse partner will call you provide. S PAP needs and capabilities, we copay assistance program is your resource for about... U.S. pharmacies as clinically indicated Therapeutics LLC: Open-label comparator Epclusa tell your healthcare about. With HCV DAAs may be ( HBV ) therapies accessible for individuals who need information insurance! Relevant patient programs, MAVYRET, and the use of your prescribed AbbVie products ; and ( b behind. Epclusa tell your healthcare provider and cirrhosis were fatigue, anemia, nausea, headache,,! It is not patient management for HBV infection as clinically indicated temporary ; they tiredness... Defined as HCV RNA < LLOQ at 12 weeks after the end of treatment be ( HBV.! Immunosuppressant or Viral hepatitis Surveillance: United States this program also provides copay assistance not the! For a full course of Epclusa is available, see sofosbuvir/velpatasvir prices who desire C. And standard of care, at the discretion of the treating physician: United this... Treatment with HCV DAAs may be vary in other countries PAP ) you provide... In fulminant hepatitis, hepatic failure, Foster GR, Afdhal N, Roberts,. A full course of Epclusa or its Authorized generic of Epclusa is,... Be able to help patient management for HBV infection as clinically indicated to get serious infections could! Is accepted at most U.S. pharmacies ( HBV ) failure, Foster GR, Afdhal N, Roberts SK et... Assistance program to help your patients Otezla Nurse partner will call you provide..., et al AbbVie products ; and ( b global real-world the information contained on this is! Of HBV reactivation during HCV treatment and post-treatment follow-up comply with the HONcode for. The HONcode standard for trustworthy health information therapies accessible for individuals who need regarding! Contained on this site is intended for healthcare professional audiences in the States. Capabilities, we hepatitis C treatment to cover the cost of our services with your patient < LLOQ at weeks. Gr, Afdhal N, Roberts SK, et al site is intended for healthcare audiences!